Gramicidin S based Mitochondrial Targeting Agents
|Organization:||University of Pittsburgh, Pa, US|
|I.P. Brief:||Available for license is a mitochondrial targeting agent with potentential treatment capabilities in many disease areas such as mitochondrial disease, hemorrhagic shock, and cancer.|
|Keywords:||Cancer, Mitochondria, Critical Care, targeting|
|Primary Industry:||Pharma & Biotech|
|Specific Market:||Platform technology for targeting Mitochondria|
Full IP Descriptions available on-site.